Medical/Pharmaceuticals
Insilico Medicine and 4B Technologies Announce Strategic Collaboration in Advancing Novel Drug Discovery for Neurodegenerative Diseases
SHANGHAI, Aug. 27, 2021 /PRNewswire/ -- Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, and4B Technologies Co., Ltd. ("4B Technologies"), a leading end-to-end innovative biopharmaceutical company focusing on nervous system diseases, signed...
2021-08-27 03:22
32337
PharmaBlock Announces the Appointment of Dr. Xudong Wei as Senior Vice President to Lead and Enhance Small Molecule CDMO Services
NANJING, China, Aug. 26, 2021 /PRNewswire/ -- PharmaBlock (300725.SZSE), an innovative chemistry products and services provider to support drug discovery, development, and commercialization, announces the appointment of Dr.Xudong Wei as Senior Vice President and Head of CDMO Business to enhance s...
2021-08-26 23:00
4406
3SBio announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development
HONG KONG, Aug. 26, 2021 /PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today unveiled its 2021 interim results. 3SBio maintained strong performance in core businesses, with core products occupying a leading market share. Meanwhile, the Company continuously increased ...
2021-08-26 22:09
6905
Everest Medicines Announces First Person Dosed in Global Phase 3 Registration Trial of Sacituzumab Govitecan-Hziy in China for Metastatic Urothelial Cancer
SHANGHAI, Aug. 26, 2021 /PRNewswire/ -- Everest Medicines
2021-08-26 21:40
5933
Modern Chinese Medicine Announces Year 2021 Interim Results
PERFORMANCE HIGHLIGHTS * Revenue increased by 8.8% to RMB171.8 million * Gross profit increased by 10.4% to RMB78.6 million * Profit after tax increased by 10.5% to approximately RMB44.1 million * The increase in revenue was primarily driven by the surge in revenue generated from the sales...
2021-08-26 20:46
5855
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800
INOVIO's global Phase 3 efficacy trial receives authorization to proceed from Brazil; other countries to follow INOVIO to conduct INNOVATE Phase 3 efficacy trial with partner Advaccine in areas of world in need of COVID-19 vaccines PLYMOUTH MEETING, Pa., Aug. 26, 2021 /PRNewswire/ -- INOVIO (NAS...
2021-08-26 20:00
4123
RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights
TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-08-26 19:56
7872
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-08-26 19:50
4172
Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)
HYDERABAD, India, Aug. 26, 2021 /PRNewswire/ -- Sai Life Sciences, a leading
globalContract Research, Development & Manufacturing Organization
2021-08-26 19:19
4271
CStone Pharmaceuticals Announces 2021 Interim Results
SUZHOU, China, Aug. 26, 2021 /PRNewswire/ -- CStone Pharmaceuticals (CStone, HKEX: 2616), a leading biopharmaceutical company focused on researching, developing and commercializing innovative immuno-oncology therapies and precision medicines, today announced 2021 financial results. "In the first...
2021-08-26 19:14
6495
Joint Commission of Taiwan reveals smart dialysis solutions at online forum
TAIPEI, Aug 26, 2021 /PRNewswire/ -- The number of patients with chronic kidney disease inMalaysia is increasing by some 10,000 annually, according to a report from the National Kidney Foundation ofMalaysia (NKF). In order to further promote cooperation betweenTaiwan and Malaysia as it relates to...
2021-08-26 17:33
3180
Elekta's Board announces establishment of philanthropic Elekta Foundation
STOCKHOLM, Aug. 26, 2021 /PRNewswire/ -- At its Annual General Meeting on August 25, Elekta's (EKTA-B.ST) shareholders approved the Board of Directors' proposal to establish the Elekta Foundation. The Elekta Foundation's mission is an important part of Elekta's environmental, social, and governan...
2021-08-26 14:21
4286
Seattle Co Develops Rapid Fingerprinting For Covid-19 Variants
First-Ever Technology Receives NIH Grant to Speed Up Availability of Testing SEATTLE, Aug. 26, 2021 /PRNewswire/ -- ID Genomics (IDG), a Seattle -based company, has invented a dipstick-based, rapid test for simultaneous identification of a large number of genetic variants of SARS-CoV-2 and has jus...
2021-08-26 04:32
1832
XABT Donates 2019-nCoV Nucleic Acid Detection Kits to Vientiane, Laos
BEIJING, Aug. 25, 2021 /PRNewswire/ -- Atsaphangthong Siphandone, Mayor of Vientiane, the capital of Laos, recently issued an honorary certificate to Beijing Applied Biological Technologies (XABT) for the donation of 2019-nCoV Nucleic Acid Detection Kits to supportVientiane's efforts at epidemic ...
2021-08-25 22:06
5172
Aqueous Ozone by BES Group Proves Effective in Killing COVID-19
SAN ANTONIO, Aug. 25, 2021 /PRNewswire/ -- Aqueous ozone by BES Group's
Multi-Purpose Ozone Bottle and Professional Ozone Spray Bottle has proved
effective in killing SARS-CoV-2, the virus that causes COVID-19 in testing by a
third-party lab at Nara Medical University inJapan.
2021-08-25 22:00
3682
First patient treated in Clarity's Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial
SYDNEY, Aug. 25, 2021 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or the "Company"), an Australian-based clinical stage radiopharmaceutical company developing next-generation products to address the growing need in oncology, is pleased to announce that the first US patient has ...
2021-08-25 21:18
6694
endpoint and THREAD Simplify DCT Operations for Key Stakeholders to Reduce Study Timelines
Integration of data capture and transactions ensures that the site and subject stay together in a unified workflow SAN FRANCISCO and CARY, N.C., Aug. 25, 2021 /PRNewswire/ -- endpoint Clinical , the leader in global interactive response technology (IRT®) for clinical trials, andTHREAD, a leading...
2021-08-25 21:00
4023
Innovent Announced 2021 Interim Results with Total Revenue of RMB 1,941.8 Million and Accelerated Global R&D Footprint
SAN FRANCISCO and SUZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-08-25 20:53
6066
Report from the Annual General Meeting 2021 in Elekta
STOCKHOLM, Aug. 25, 2021 /PRNewswire/ -- Elekta AB (publ) has held its Annual General Meeting on25 August 2021. In light of the extraordinary situation prevailing as a result of Covid-19, the Meeting was conducted by advance postal vote, without physical attendance. A statement from the CEO and P...
2021-08-25 20:50
5153
Tigermed Reports 2021 Interim Results with Strong Financial Growth
HANGZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (stock code: 300347.SZ / 3347.HK), a leading provider of innovative clinical research solutions for biopharmaceutical and medical device industry, reports its interim results for the six months endedJune 30, 202...
2021-08-25 20:49
6951
Week's Top Stories
Most Reposted
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 309 media titles]
2026-07-30 10:45
Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
[Picked up by 295 media titles]
2026-08-04 07:00
J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 294 media titles]
2026-07-30 15:00Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition
[Picked up by 291 media titles]
2026-08-04 14:30
Most Read
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
2026-07-30 10:45
19242
